Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 3/20 | 0.58 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.54 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.54 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.54 |
| ▸ | KMO | O15229 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 5/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | HPGD | P15428 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | DHODH | Q02127 | 1/20 | 0.52 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.51 |
| ▸ | MKNK1 | Q9BUB5 | 3/20 | 0.49 |
| ▸ | MKNK2 | Q9HBH9 | 3/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23095162 | 1.00 | CYP19A1 (0.58) | CYP19A1CYP11B1CYP11B2CYP17A1KMO | |
| SCHEMBL17808012 | 1.00 | CYP19A1 (0.58) | CYP19A1CYP11B1CYP11B2CYP17A1KMO | |
| SCHEMBL19397480 | 1.00 | CYP19A1 (0.58) | CYP19A1CYP11B1CYP11B2CYP17A1KMO | |
| SCHEMBL22074506 | 0.98 | CYP19A1 (0.57) | CYP19A1CYP11B1CYP11B2CYP17A1KMO | |
| SCHEMBL19397372 | 0.98 | CYP19A1 (0.60) | CYP19A1CYP11B1CYP11B2CYP17A1KMO | |
| SCHEMBL19443926 | 0.98 | CYP19A1 (0.60) | CYP19A1CYP11B1CYP11B2CYP17A1KMO | |
| SCHEMBL19397373 | 0.98 | CYP19A1 (0.60) | CYP19A1CYP11B1CYP11B2CYP17A1KMO | |
| SCHEMBL19397417 | 0.97 | CYP19A1 (0.58) | CYP19A1CYP11B1CYP11B2CYP17A1KMO | |
| SCHEMBL22663977 | 0.97 | CYP19A1 (0.57) | CYP19A1CYP11B1CYP11B2CYP17A1KMO | |
| SCHEMBL19650738 | 0.97 | CYP19A1 (0.62) | CYP19A1CYP11B1CYP11B2CYP17A1KMO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10580995-B2 | Compounds for organic electroluminescent components and organic electroluminescent devices using the same | E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) | 2020-03-03 | — | — | US | disclosed |
| US-20170279054-A1 | COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME | E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) | 2017-09-28 | — | — | US | disclosed |
| US-20170279054-A1 | COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME | E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) | 2017-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10580995-B2 | Compounds for organic electroluminescent components and organic electroluminescent devices using the same | C1S, AOC2, L1CAM | CYP19A1 515/4885CYP11B1 323/4885CYP11B2 389/4885 |
| US-20170279054-A1 | COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME | L1CAM, C1S, F10 | CYP19A1 673/4885CYP11B1 799/4885CYP11B2 1013/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.